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Executive
Executive Summary
More than three years after the European Commission's communication on the regulatory aspects of nanomaterials, numerous questions remain regarding the practical effectiveness of existing European Union law to manage nanomaterials. REACH, the primary EU regulation on chemicals, is assumed to be the regulatory cornerstone for addressing the health, safety and environmental risks of nanomaterials. In particular, REACH registration is described as the ideal tool to fill the problematic knowledge gap on nanomaterials. However, the limited information gathered in the first registration phase demonstrates that REACH is not living up to expectations for nanomaterials.
The study identifies four areas in which REACH's registration provisions fail to account for the specificities of nanomaterials:
1. Identifying nanomaterials: REACH currently does not define nanomaterials and leaves to the registrant the final decision of determining whether a substance is a nanomaterial. As a result, the final decision to identify substances as nanomaterials is made by the registrants according to their own criteria. In addition to creating confusion in the implementation of REACH, this situation is likely to severely impair efforts to use REACH as the main regulatory tool for gathering information on nanomaterials on the market and defining and implementing appropriate risk management measures if needed.
The limited information gathered in the first registration phase demonstrates that REACH is not living up to expectations for nanomaterials.
2. Phase-in status of nanomaterials: REACH distinguishes new and existing substances, between substances that were already on the market before its entry into force (so called "phase-in substances) and new substances (so called non phase-in substances). As REACH is currently implemented, if a material is considered a phase-in substance in its bulk form, then a nanomaterial sharing the same chemical composition will automatically benefit from the bulk version's phase -in status, regardless of its newness. As a consequence, nanomaterials derived from a bulk phase-in substance, or sharing the same chemical composition, will not be registered before the 2013 deadline if they are manufactured or imported in quantities above 100 tonnes per year per registrant. Such materials manufactured or imported in quantities of 1-100 tonnes per year per registrant will not be registered until 2018, further extending the knowledge gap surrounding nanomaterials. Because most nanomaterials currently on the market are derived from 'parent substances" that benefit from a phase-in status, the vast majority of nanomaterials currently marketed benefit from delayed registration deadlines in direct contradiction with the "no data, no market" principle underlying REACH.
3. Tonnage thresholds and nanomaterials: Production volumes play a significant role in determining whether and how substances are accounted for under REACH. The overall rule of thumb is that the higher the volume, the more data is required, and the sooner the registration.
REACH registration requirements apply only for production volumes of one tonne or more per year per manufacturer or importer. This volume threshold is grossly inadequate for nanomaterials, usually produced in much smaller quantities. Furthermore, in the few cases in which nanomaterials are produced in volumes above the one tonne/year per registrant threshold, most of those nanomaterials will benefit from a phase-in status. As a result, the information required by the registration dossier will be limited to the physicochemical properties of the substance, excluding any toxicological and eco-toxicological information, which may otherwise be required. Nor does the dossier include exposure information, which is currently required only for substances of "very high concern". Similar concerns apply to the availability of information down the supply chain.
Risk assessment provisions: According to the Scientific Committee on Emerging and Newly
Identified Health Risks (SCENIHR) and independent researchers, and notwithstanding other limitations discussed above, any risk assessment information made available on a nanomaterial in the context of REACH would be based on testing guidelines that fail to consider the special hazards and exposure pathways of nanomaterials. Furthermore, if a bulk substance is characterized as non-hazardous, as is the case for the vast majority of substances from which nanomaterials are derived, this classification will be extended to the nano-form of the substance, with no additional requirements to generate data on specific nano-form effects. Therefore, a nanomaterial could move through its entire life-cycle without further requirements to assess its properties. Given these limitations, REACH in its current form does not equip decision-makers to manage the risks of nanomaterials.
Several REACH Implementation Projects on Nanomaterials (RIPoN 1, 2 and 3) were designed to address these concerns without modifying the text of the regulation. RIPoN 1, in particular, aimed at adapting the substance identification rules (defined in a Technical Guidance Document (TGD)) to clarify the implementation of REACH to nanomaterials. This expert group proposed two options: addressing nanomaterials as 1) "well defined substances" or as 2) "Substances of defined chemical composition and additional identifiers".
Although these options might improve the situation to a limited extent, most of the issues identified above would remain. In particular, the problems related to the tonnage band rules and the inadequacy of the traditional hazard and exposure testing guidelines persist. Furthermore, substance identification rules are not binding, so attempts to address the gaps for nanomaterials by modifying these rules could create confusion in implementation and thwart efforts to use REACH as the main regulatory tool for nanomaterials. If REACH is to serve as the regulatory cornerstone for nanomaterials, it will require more profound changes of the regulatory framework.  Modifying Article 14(1) to require that registration dossiers for nanomaterials categorically include a Chemical Safety Assessment, in order to reach the "high level of protection of human health and the environment;" and  Finally, updating testing and risk assessment provisions and guidelines to include specific nanomaterials provisions, through modifications of Annexes VI to X as well as technical guidance documents.
These proposals would go a long way to ensure that the registration process under REACH generates necessary information on nanomaterials. Additional modifications of other REACH provisions, annexes, and guidance would be required to address shortcomings of other core elements of REACH, including evaluation, authorisation, and restriction.
Instead of modifying REACH itself, a possible alternative for addressing nanomaterials would be to develop a stand-alone regulation specifying how REACH tools and provisions are to be applied to nanomaterials.
Option 2: Developing a stand-alone regulation Instead of modifying REACH itself, a possible alternative for addressing nanomaterials would be to develop a stand-alone regulation specifying how REACH tools and provisions are to be applied to nanomaterials. This regulation could list general principles for the management of nanomaterials, indicate that all terms would be consistent with their definition in REACH and define nanomaterials using the Commission proposal. Other provisions would, among other things, establish a production/import threshold of 10 kilograms for registration, together with registration deadlines. This stand-along regulation could serve as a "nano patch," providing a simpler and more elegant solution to adapting REACH to the special properties of nanomaterials. By creating a flexible instrument with simplified revision procedures, it would be possible to adapt to changing experience with nanomaterials, without adding further layers of complexity to REACH. This study will therefore focus on the adaptations to REACH needed to ensure that nanomaterials are properly registered and that the registration phase provides the information necessary to further implement the risk management tools integrated in the REACH framework.
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After a brief summary of REACH provisions relevant to the registration of nanomaterials, the study will identify obstacles and legal shortcomings that impede the successful registration of nanomaterials, review the possible role of substance identification rules in addressing these shortcomings and propose policy options to remedy the remaining gaps.
SECTION 2 / Key registration provisions for nanomaterials
The registration provisions of REACH are founded on the "no data, no market" principle.
These provisions require manufacturers and importers to submit a minimum set of information on a substance in order to market that substance within the EU. 12 This general obligation to register nanomaterials applies solely for those manufactured or imported in quantities of 1 tonne 11 REACH, Title II, Arts 5-24.
or more per year. 13 The registration dossier must be submitted to the European Chemicals Agency (ECHA) for substances manufactured or imported in the EU above the 1 tonne threshold (or, for substances in articles, that are intended for release during normal usage of the article), unless stated otherwise.
14 Under this regulation, registrants are responsible for complying with data production and testing requirements under the Regulation. The registration deadline and information requirements vary depending on the hazard profile and the quantity manufactured or imported.
Four tonnage bands act as regulatory thresholds (1 -10 tonnes, 10-100 tonnes, 100-1,000 tonnes, and 1,000+ tonnes). Information requirements become progressively more extensive as the tonnage band increases. The rationale behind this approach was the assumption that a higher tonnage means a higher exposure, which implies higher risks posed by the substance.
The emergence of nanomaterials might challenge this assumption. 14 REACH, Art 7. Although for substances in articles meeting the criteria in Art 57 and identified in accordance with Art 59(1), a producer or importer must notify the Agency in accordance with Art 7(4) if the substance is presenting those articles in quantities totaling over 1 tonne per producer/importer per year, and the substance is present in, those articles above a concentration of 0,1% w/w. 15 
SECTION 3 / Applying REACH provisions to nanomaterials
REACH contains strong provisions to gradually collect minimum data for all substances available in the EU market in quantities of more than one tonne. REACH provisions are further complimented by extensive Technical Guidance Documents (TGDs) that specify how to implement the various provisions. However, because both REACH and the TGD were drafted before nanotechnology was widely used, neither the regulation nor the guidance are fully adapted to answer the questions raised by the special properties of nanomaterials. There are four major gaps for nanomaterials under Registration: (1) the identification of nanomaterials; (2) 'phase-in' status; (3), tonnage thresholds; and (4) risk assessment methods.
Identifying nanomaterials
There is a general consensus that nanomaterials are not excluded by the substance definition in REACH. But REACH provides only limited opportunities to identify them as such 21 and to take into account their special characteristics. The limitations in identifying nanomaterials are particularly severe when a bulk substance with a similar chemical composition exists.
Although they may be variants of bulk substances, sharing the molecular structure or the same chemical composition, nanomaterials possess unique properties, which are exhibited solely at the nano-scale. 
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The second REACH Implementation Project on Nanomaterials (RIP-oN2), focused on information required for characterising and evaluating nanomaterials, proposed a set of modifications of a TGD that was considered poorly suited to nanomaterials (i.e., with regards to preparation, exposure quantifications, measurement, dose metrics, etc.). Recommendations from RIPoN2 address a number of domains (including physiochemical properties, toxicological, ecotoxicologial endpoints, and more), which would require a modification of the REACH annexes. However, for such modifications, once adopted, to be implemented, nanomaterials must first be systematically identified. The fifth version of the International Uniform Chemical Information Database (IUCLID5) system allows registrants to identify nanomaterials in registration dossiers. REACH, however, does not explicitly define nanomaterials. Therefore, the final decision in determining whether a substance is a nanomaterial rests with the registrant.
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As a result, it is the discretion of registrants to identify substances as nanomaterials according to their own criteria. In addition to creating confusion in the implementation of REACH, this situation is likely to thwart efforts to use REACH as the main regulatory tool to gather information on nanomaterials on the market and to define and implement appropriate risk management measures if needed. 
The "phase-in" status of nanomaterials
Under REACH, substances are currently identified by their chemical composition alone.
When two substances share the same chemical composition, they are considered to be the same substance. As a consequence, if a substance exists both in the bulk and nano form, and if the bulk substance is a phase-in substance, a nanomaterial sharing the same chemical composition will automatically benefit from the bulk version's phase-in status, regardless of its new- 
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As a result, the availability of toxicological and ecotoxicological information on the bulk form does not justify the phase-in status granted to nanomaterials. This results in nanomaterials entering and remaining on the market with little or no information available regarding their potential risks, in direct contradiction with the "no data, no market" principle underlying REACH. This undermines the effectiveness and credibility of REACH as the primary regulatory tool to bridge the knowledge gap on nanomaterials.
Tonnage thresholds
Production volumes play a significant role in determining whether and how substances are accounted for under REACH. The general rule of thumb is that the higher the volume, the more data is required, and the sooner the registration. 34 Regulatory thresholds are based on four tonnage bands (1 -10 tonnes, 10-100 tonnes, 100-1,000 tonnes, and 1,000+ tonnes).
Registration of nanomaterials is key to their regulation since it allows for the collection of the necessary information fundamental to the application of other REACH mechanisms, such as restriction and authorisation. Moreover, the information provided on nanomaterials under REACH has significance beyond REACH itself. According to the Commission, this information "will serve as input to other regulation, such as worker protection, cosmetics and environmental protection [and] complements product legislation (e.g., general product safety) to the extent that this does not cover environmental aspects."
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Ever since REACH was adopted, the relevance of REACH tonnage thresholds to nanomaterials has been questioned. 36 In effect, the requirement for registration laid down in Article 6 (1) 34 There are exceptions to this principles relating to the registration of substances meeting certain toxicity criteria (i.e.: Carcinogen, Mutagen, Reprotoxic, Persistent or bio-accumulative). This exception is however not deemed relevant in the context of the present study, as enduring data gap preclude that any nanomaterials be the object of such toxicity classification in the near future. and "hampered by the lack of definitive inventory on the types and uses of nanosubstances".
37
Based on the very small quantities in which nanomaterials are marketed, 38 however, it seems likely that the production and import of most nanomaterials would fall below the one tonne threshold required for even basic regulation under REACH. It therefore must be assumed that the standard principle in Article 5 of REACH-No data, no market"-is ineffective with respect to many nanomaterials. 39 The German Advisory Council on the Environment (SRU) suggests that "a core data set should still have to be submitted if a nanomaterial is produced in quantities of less than 1 tonne per year."
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Even in the few cases in which nanomaterials are produced in volumes above the one tonne/year per registrant threshold, most nanomaterials will still benefit from phase-in status derived from their bulk counterparts. 41 Consequently, the information set required by the registration dossier will be limited to the physicochemical properties of the substance, excluding any toxicological and eco-toxicological information, 42 which may otherwise be required. Nor will it include exposure information, which is only required for "substances of very high concern.
43
Similar concerns apply to the availability of information down the supply chain.
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A detailed CSA, which mandates human health, physicochemical, and environmental hazard assessment, is only mandated for substances manufactured or imported above the ten 37 R. tonne threshold/year by a single registrant. 45 Because most nanomaterials are likely to produced in low volumes (under the 10 tonne threshold), CSA will be unavailable for the great majority of nanomaterials.
Risk assessment provisions
REACH rules for the provision of physicochemical, toxicological and ecotoxicological data, as well as CSA performance criteria reflect methodologies developed for traditional substances.
Several commentators have highlighted the need to modify both the rules and the implementation guidelines in order to effectively address the special risks posed by nanomaterials.
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The 
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Given these limitations, REACH in its current form does not equip decision-makers for effective nano-regulation because it would lead to decisions based on hazard and exposure assessment methods ill-suited to properly assess the risks of nanomaterials.
Indeed, the United Kingdom's Royal Commission on Environmental Protection (RCEP) has
highlighted that REACH may actually have an indirect but adverse effect on risk data generation for nanomaterials. 61 Under the current regime, if a bulk substance is characterized as hazardous, the supplier will be required to provide further information on the nature of the hazard and the possible risks involved. But if the material is non-hazardous, as is the case for the vast majority of substances from which nanomaterials are derived, this classification will be extended to the nano-form of the substance, with no additional requirements to generate data on specific nano-form effects. From there on, the substance could move through its entire lifecycle without further assessment, "despite the possibility that, although it is not considered harmful to human health or the environment in its approved use, it might have the capacity for adverse impacts at some other stage, for example, as a result of release of the products of 
Summary: Four gaps regarding nano within REACH
REACH in its current form demonstrates four distinct and significant gaps with regard to the effective regulation of nanomaterials:
1. As REACH currently stands, it is impossible to formally identify a nanomaterial with consistency across the board. This creates confusion and serious doubts as to the capacity of REACH to generate comprehensive data on nanomaterials currently being marketed.
Since substance identification within REACH is exclusively based on a substance's chemical composition, a nanomaterial sharing the same chemical composition as an existing ('phase-
in') bulk substance will automatically benefit from the bulk form's phase-in status, resulting in a delayed registration deadline.
3. Existing tonnage thresholds far exceed the quantities in which most nanomaterials enter the EU market, thus greatly limiting the information required for registration of nanomaterials.
4. Finally, and in addition to the foregoing limitations, any risk assessment information made available in the context of REACH would rest on inadequate testing guidelines, very seriously limiting its potential utility.
If regulators intend to use REACH as the "cornerstone for addressing health, safety and environmental risks" of nanomaterials, 63 it is imperative that these shortcomings be remedied.
Given these limitations, REACH in its current form does not equip decisionmakers for effective nanoregulation.
SECTION 4 / Addressing the nano gaps: the limits of substance identification
In an effort to address these concerns and evaluate the applicability of existing TGD (and ultimately of REACH) to nanomaterials, the Commission set up three REACH Implementation
Projects on Nanomaterials (RIP-oN). The first of these RIP-oNs, addresses the specific issues revolving around substance identification. Having sought to develop scientific and technical advice on how to establish the substance identity of nanomaterials, the RIP-oN 1 advisory report highlights the existing divergence of opinions on the adequacy of current identification parameters, and presents two options for adapting substance identification rules to nanomaterials: (1) treating nanomaterials as "well defined substances" or (2) as "substances of defined chemical composition and additional identifiers." Yet the report leaves unaddressed the underlying questions of how to adapt substance identity rules under REACH to nanomaterials. Nor does it address the material consequences that selecting one or another of the options can have on potential registration dossiers of nanomaterials. This section explores the impact of these choices in addressing the inherent gaps identified in the previous section. As a preliminary remark, it is important to consider that guidance documents (including those on substance identification)
are not binding. Thus, if a definition of "nanomaterial" were to be included in such documents, registrants would still retain flexibility in deciding whether to use this definition in their registration process. Modification of the guidance document alone would therefore be insufficient to adapt REACH to effectively regulate nanomaterials.
Nanomaterials as "Well-Defined Substances"
Nanomaterials derived from a bulk chemical
In its current form, REACH substance identification rules are based on chemical composition alone. 64 Considering nanomaterials as well defined substances 65 means that a nanomaterial sharing the same molecular composition as a chemical in the bulk form will be automatically assimilated to its bulk counterpart. As a consequence, other characteristics of the substance, such as its size, will not be considered identifiers for purposes of substance identification under REACH, but rather as a "characteriser." 66 Consequently, traditional substance identity rules will apply; requiring not only that the nano and bulk versions be registered as one substance, but also that the substance's tonnage threshold be calculated based on the total volume of substance (both bulk and nano combined) manufactured or imported by each party.
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This has two main implications.
First, the assimilation of the nanomaterial and the bulk as one substance for registration purposes enables, in theory, the inclusion of the former under REACH regulation because of the combined tonnage. In practice, however, this may not be enough to remedy the problem identified in section 3.3. It would only bring nanomaterials into the REACH regime insofar as both the bulk and nanomaterial are manufactured or imported by the same legal entity. In effect, REACH tonnage thresholds are defined by the volumes applicable to each potential registrant.
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In cases where the nanomaterial is manufactured or imported by a different legal entity than the one who manufactures or imports the bulk (regardless of whether they are regarded as one substance) tonnage thresholds will be considered independently from one another.
64 ECHA 2011 Guidance, supra note 477, at 14, §4.1 65 ECHA 2011 Guidance, supra note 477 at 14 §4.1; at 18, §4.2.
66 Advisory Report for the RIP-oN 1 process, supra note 22, at 20, § 4.1.1.1 67 Commission Follow-up to the 6 th REACH CA Meeting, supra note 22 , at 6.
68 REACH, Art 6, 12.
Second, if nanomaterials are considered effectively inseparable from the bulk substance, the registration requirements under REACH provide registrants with the flexibility to decide whether or not to include information relevant to the nano-form: There is no binding obligation. The Commission opines that "all relevant information" on nanomaterials, "covering the properties, uses" and "any relevant classification and labelling" should be included in the dossi- ard classification. However, according to the text, 75 identifiable data must be readily "available", meaning that there is no obligation to generate new data on a given substance.
Considering present knowledge gaps on nanomaterials and the newness of the technologies, it can only be assumed that the "available" information to which registrants will refer to in the dossiers will relate solely or at least overwhelmingly to the bulk form of the chemical.
In addition, when actually evaluating the collected hazard information, the CLP only requires that registrants "consider", rather than mandatorily take into account, the "forms, or physical states" of the substance in the final classification decision. 76 It follows that, contrary to the views of industry experts as presented in the Rip-oN 1 advisory report, there is no binding obligation to include nano-specific properties such as size, in the classification of substances under the CLP Regulation, and by consequence in the registration dossier.
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Even the registration dossier update requirement may not adequately compensate for There is no binding obligation to include nano-specific properties such as size, in the classification of substances under the CLP Regulation, and by consequence in the registration dossier.
Nanomaterials as "Substances of Defined Chemical Composition and Additional Identifiers"
As demonstrated above, while generally well-defined substances can be "completely Making REACH the "cornerstone for addressing health, safety and environmental risks in relation with nanomaterials" will therefore require a more substantial modification of the current regulatory framework.
SECTION 5 / Policy recommendations
Although REACH provides a good foundation for regulating conventional chemicals within the EU, a closer look at its mechanisms reveals significant deficiencies with respect to nanoregulation. 91 REACH tools, which are de facto applicable to nanomaterials, cannot bridge the existing information gap until they are adapted to the specific characteristics of nanomaterials.
As noted by the European Parliament, lack of appropriate data on the safety and use of marketed nanomaterials jeopardizes the concept of a "safe, responsible, and integrated approach" 92 to nanotechnologies advocated by the European Union, preventing rather than promoting the protection of health, safety, and the environment.
The previous sections demonstrate that addressing the shortcomings identified in this study will require more than just updating the REACH TGD. This section discusses two policy options for filling the gap and explores the advantages and disadvantages of each option.  In order to specifically address the delays arising from "phase-in" status outlined in Section 3.2 of this study, Article 3(20) should further specify that nanomaterials are not considered phase-in substances.
 In order to account for the low production volume of most nanomaterials on the market and ensure that a core data set is submitted even for nanomaterials produced in quantities of less than 1 tonne per year, the implementation of tonnage triggers should be adapted to nanomaterials. To this end, an Article 7(4)bis should be introduced with specific tonnage triggers for substances within the scope of the definition of 'nanomaterials'. This modification would, in turn, require a corresponding modification of Article 6.
 Furthermore, it is necessary to modify Article 14(1) to require that registration dossiers for nanomaterials categorically include a CSA, in order to respond to existing concerns relating to the toxicity of some nanomaterials and the existing knowledge gap, and in order to reach the "high level of protection of human health and the environment."
 Finally, to adapt the testing requirements and risk assessment procedures applicable to nanomaterials, thus addressing the gap outlined in Section 3.4 while also Considering the complexity of REACH revision processes, in particular for the revision of the core of the text, a number of stakeholders, including the Commission, have questioned the advisability and/or feasibility of renegotiating REACH itself. In this context, they recommend addressing the identified shortcomings of REACH, in particular in relation to nanomaterials, through alternative methods.
Option 2: Developing a stand-alone regulation
In order to avoid modifying REACH itself, while ensuring its effectiveness in addressing the unique characteristics of nanomaterials, it is possible to add a "nano patch" to the regulation in the form of a stand-alone regulation. Such a regulation would specify how REACH tools and provisions should be applied with respect to nanomaterials. To be effective, the regulation should include the following basic elements:
 A preamble that sets forth general principles for the management and governance of nanomaterials and indicate that all terms are used in accordance with their definition in REACH except as otherwise expressly provided;
 A definition of "nanomaterials" (or "nano-substance" to adhere to REACH terminology) in accordance with the definition proposed by the Commission;
 A specification for how the REACH concept of multi-constituent substance will be applied to nano-substances, to address the issue of coated nanomaterials;
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 A requirement that all manufacturers and importers of nanomaterials in quantities over an appropriate tonnage shall submit a registration to ECHA (10kg is considered an appropriate precautionary thresholds to account for nanomaterials specificities while limiting unnecessary burden), together with subsequent tonnage thresholds to implement the REACH incremental approach.
The specifics of the registration would be cross-referenced to the relevant section in REACH and adapted where necessary. As an example, such adaptation would relate to specific tonnage triggers, registration deadlines and other aspects such as the requirement for a CSA.
Similarly, the regulation annexes would specify, via a cross-reference mechanism to REACH annexes, where the relevant sections would differ for nanomaterials. Specific information requirements and deviation from the original REACH annexes provisions would require further refinement, which could be the object of a similar subsequent study.
A stand alone "nano patch" would provide a simple and elegant solution for adapting REACH to the specificities of nanomaterials. It could furthermore be conceived as flexible instrument with simplified revision procedures. It would thus be possible to adapt nanoregulation regularly without adding further layers of complexity to REACH.
A stand alone "nano patch" would provide a simple and elegant solution for adapting REACH to the specificities of nanomaterials.
SECTION 6/ Conclusion
There is no doubt that REACH provides an incremental approach that could be very useful in collecting much needed information regarding nanomaterials and implementing further management measures. As the regulation currently stands, however, it contains gaps that render it completely ineffective for the regulation of nanomaterials. These gaps allow nanomaterials to enter the EU market with little or no information available regarding their potential risks, in direct contradiction with the "no data, no market" principle.
Efforts to address these issues have been undertaken, but proposals fall short of providing adequate solutions. To date, all of these proposals have focused on using the non-legally binding guidance documents to address these gaps. Our analysis demonstrates that revisions to these guidance documents alone will be inadequate to address gaps and shortcomings present in the regulation itself. While renegotiating REACH to include specific provisions on nanotechnology would be theoretically feasible, it appears practically impossible, as well as inadvisable in the current political context.
An alternative solution-better adapted to the specific context of nanomaterials-is available in the form a stand alone "nano-patch" to REACH that would tailor the REACH mechanisms to nanomaterials. Such a stand alone regulation would establish clear and legally binding provisions applicable to nanomaterials, thus providing a transparent and certain legal environment for the safe production and use of nanomaterials in the EU without adding complexity to the already complex instrument that is REACH. This solution would have the further advantage of being more flexible, and would make it possible to adapt the legal framework for nanomaterials more easily as our understanding grows. CIEL is looking forward to working with all interested parties and stakeholders to develop a blue print for such a "nano-patch"
and fully realize REACH's potential as the regulatory cornerstone for addressing the health, safety and environmental risks of nanomaterials.
